Results 51 to 60 of about 5,387 (192)

Terapevtski potencial vitamina A, retinoidov in karotenoidov za preprečevanje in zdravljenje raka sečnega mehurja

open access: yesZdravniški Vestnik
Rak sečnega mehurja je v svetovnem merilu 10. najpogostejši rak z izjemno visoko ponovljivostjo. Slovenska incidenca, umrljivost in prevalenca so pri tem raku v primerjavi z drugimi evropskimi državami in svetom nadpovprečne.
Daša Zupančič, Larisa Tratnjek
doaj   +1 more source

Development of Betalactam‐Predictor: A Clinical Decision Tool for Delabeling Low‐Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy

open access: yesAllergy, Volume 81, Issue 8, Page 2885-2897, August 2026.
BL‐Predictor has emerged as a new tool for delabeling penicillin allergy. External validation has shown a specificity of 93% for detecting low‐risk patients. This score could potentially reduce diagnostic costs and the negative consequences associated with incorrect antibiotic allergy labels.
Marina Labella   +14 more
wiley   +1 more source

Cations divalents : ions per a la nanomedicina del segle XXI [PDF]

open access: yes, 2021
El correcte funcionament del cos humà depèn, entre altres factors, de la concentració adequada de cations divalents, elements amb doble càrrega positiva en superfície capaces d'interactuar amb diferents molècules al mateix temps.
Sánchez, Julieta M.   +4 more
core   +1 more source

La UAB-CEI organitza el primer workshop en nanomedicina [PDF]

open access: yes, 2012
El proper 5 de juny de 2012 es celebrarà el Workshop en Nanomedicina a l'Hotel Campus de la UAB per promoure la recerca i la innovació en aquest camp en l'entorn del Campus d'Excel·lència Internacional UAB-CEI.

core   +1 more source

Patrones moleculares asociados a patógenos: ¿héroes o villanos en nanomedicina?

open access: yesMundo Nano, 2018
En nanomedicina, el destino de nanopartículas al interior de un organismo se encuentra fuertemente influenciado por la respuesta del hospedero. Para muchas aplicaciones biomédicas, el reconocimiento de nanopartículas por el sistema inmune constituye uno
Luz María López Marín   +1 more
doaj   +1 more source

Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy

open access: yesAllergy, Volume 81, Issue 8, Page 2898-2909, August 2026.
DeAns with defined nanoscale structure reveal that conjugate size and determinant density govern IgE‐mediated effector‐cell activation in AX allergy. All DeAn generations bind to sIgE in inhibition immunoassay, but only larger DeAns trigger FcεRI‐dependent responses in mouse MC, huRBL‐2H3, and LUVA cells.
Amene Tesfaye Ayane   +12 more
wiley   +1 more source

Nanobiotecnologia i nanomedicina [PDF]

open access: yes, 2014
La nanobiotecnologia és la confluència entre la nanotecnologia i la biotecnologia. Inclou tots els mètodes i tècniques a nanoescala (109 m) que poden servir per controlar i caracteritzar la matèria biològica.
Samitier i Martí, Josep
core  

Indocyanine Green Nanoparticles: Are They Compelling for Cancer Treatment?

open access: yesFrontiers in Chemistry, 2020
Indocyanine green (ICG) is a Food and Drug Administration–approved near-infrared fluorescent dye, employed as an imaging agent for different clinical applications due to its attractive physicochemical properties, high sensitivity, and safety.
Marta Sevieri   +7 more
doaj   +1 more source

Association of Post‐Oral Glucose Tolerance Test Hypoglycaemia With Clinical Features, Incident Diabetes and Mortality in the Di@bet.es Cohort

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7430-7442, August 2026.
ABSTRACT Aims To investigate the association of post‐oral glucose tolerance test (OGTT) hypoglycaemia with clinical features, incident diabetes and mortality. Materials and Methods This population‐based cohort study included 2924 adults (median age 49 years, 1680 women) without known diabetes who underwent a 75‐g OGTT as part of the Di@bet.es Study ...
Tomás González‐Vidal   +14 more
wiley   +1 more source

Real‐world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study

open access: yesCancer, Volume 132, Issue 14, 15 July 2026.
ABSTRACT Background Chemotherapy schemes have historically shown low efficacy in patients with metastatic melanoma and have been replaced by immunotherapy and targeted therapy. This work aimed to study whether chemotherapy remains an option after progression to immunotherapy in specific contexts.
Miguel‐Ángel Berciano‐Guerrero   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy